views
Solvex Edibles IPO GMP Details and Investment Outlook
The Solvex Edibles IPO, a fixed-price SME IPO, has drawn investor attention due to its strong fundamentals and recent financial performance. Priced at ₹72 per share, the company seeks to raise ₹18.87 crore through a fresh issue of 26.2 lakh shares. The IPO was open for subscription from September 22, 2025, to September 24, 2025, offering retail investors an entry into India’s expanding edible oil and by-products industry.
Solvex Edibles IPO GMP Today
One of the most followed indicators in IPO investing is the Grey Market Premium (GMP). As of September 24, 2025, the Solvex Edibles IPO GMP is reported at ₹0. This means shares are currently trading at par with the issue price in the grey market, indicating a potential listing price of ₹72 per share. Effectively, this suggests a 0% listing gain if market sentiment remains unchanged.
While the GMP reflects the near-term outlook, it is highly dynamic and can fluctuate until listing day. Investors should consider both fundamentals and market conditions rather than relying solely on GMP before making investment decisions.
Key IPO Dates
-
Opening Date: September 22, 2025
-
Closing Date: September 24, 2025
-
Allotment Finalization: September 25, 2025
-
Listing Date: September 29, 2025
-
Lot Size: Minimum application of 1,600 shares, requiring an investment of ₹1,15,200 at the issue price.
Company Overview
Founded in 2013, Solvex Edibles Limited operates in the edible oils and agro-based by-products segment. The company specializes in manufacturing, distribution, and sales of solvent-extracted rice bran oil along with by-products such as:
-
De-oiled cakes
-
Mustard oil
-
Mustard cakes
These products serve as critical inputs for the FMCG sector and are also widely used in cattle, poultry, and fish feed industries.
The company’s manufacturing unit in Uttar Pradesh boasts a processing capacity of 200 TPD (tonnes per day), reflecting its operational strength.
Financial Performance
Solvex Edibles has showcased remarkable financial growth in recent years:
-
Revenue: Jumped from ₹71.94 crore in FY24 to ₹136.46 crore in FY25, almost doubling year-on-year.
-
Profit After Tax (PAT): Increased 4x, rising from ₹1.01 crore in FY24 to ₹4.09 crore in FY25.
-
EBITDA & PAT Margins: Both improved significantly, indicating enhanced operational efficiency and profitability.
Such strong growth underscores the company’s resilience in a competitive industry and positions it well for future expansion.
Use of IPO Proceeds
The funds raised from the IPO will be strategically allocated towards:
-
Capital expenditure to upgrade facilities and expand capacity.
-
Repayment of borrowings, thereby strengthening the balance sheet.
-
General corporate purposes, ensuring operational efficiency and liquidity.
This financial plan reflects the company’s intent to improve long-term sustainability, reduce debt levels, and enhance production capabilities.
Investment Outlook
While the Solvex Edibles IPO GMP currently stands at zero, suggesting no immediate listing gain, investors should not overlook the company’s robust financial trajectory and sector potential. The edible oils and by-products market in India continues to expand, backed by rising demand from FMCG companies and the animal feed industry.
For investors with a medium to long-term horizon, the IPO offers exposure to a growing sector and a company with improving fundamentals. However, those purely eyeing listing gains may find the current GMP less attractive.

Comments
0 comment